State Street’s Corbus Pharmaceuticals CRBP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$380K Sell
55,092
-168,378
-75% -$1.16M ﹤0.01% 3677
2025
Q1
$1.19M Sell
223,470
-5,130
-2% -$27.2K ﹤0.01% 3392
2024
Q4
$2.7M Sell
228,600
-366,976
-62% -$4.33M ﹤0.01% 3215
2024
Q3
$12.3M Buy
595,576
+153,243
+35% +$3.16M ﹤0.01% 2487
2024
Q2
$20M Buy
442,333
+406,354
+1,129% +$18.4M ﹤0.01% 2174
2024
Q1
$1.41M Buy
35,979
+22,800
+173% +$895K ﹤0.01% 3385
2023
Q4
$79.6K Hold
13,179
﹤0.01% 4099
2023
Q3
$88.8K Hold
13,179
﹤0.01% 4137
2023
Q2
$103K Hold
13,179
﹤0.01% 4231
2023
Q1
$95.8K Sell
13,179
-5
-0% -$36 ﹤0.01% 4336
2022
Q4
$43.7K Hold
13,184
﹤0.01% 4588
2022
Q3
$65K Hold
13,184
﹤0.01% 4594
2022
Q2
$100K Hold
13,184
﹤0.01% 4535
2022
Q1
$210K Buy
13,184
+1,277
+11% +$20.3K ﹤0.01% 4364
2021
Q4
$220K Hold
11,907
﹤0.01% 4310
2021
Q3
$364K Buy
11,907
+150
+1% +$4.59K ﹤0.01% 4102
2021
Q2
$645K Sell
11,757
-39,904
-77% -$2.19M ﹤0.01% 3769
2021
Q1
$3.05M Buy
51,661
+7,209
+16% +$426K ﹤0.01% 3261
2020
Q4
$1.67M Sell
44,452
-509,486
-92% -$19.1M ﹤0.01% 3428
2020
Q3
$29.9M Buy
553,938
+452,402
+446% +$24.4M ﹤0.01% 1796
2020
Q2
$25.6M Buy
101,536
+62,982
+163% +$15.9M ﹤0.01% 1896
2020
Q1
$6.06M Buy
38,554
+1,165
+3% +$183K ﹤0.01% 2530
2019
Q4
$6.12M Buy
37,389
+739
+2% +$121K ﹤0.01% 2755
2019
Q3
$5.36M Buy
36,650
+1,951
+6% +$285K ﹤0.01% 2753
2019
Q2
$7.21M Buy
34,699
+3,644
+12% +$758K ﹤0.01% 2640
2019
Q1
$6.48M Buy
31,055
+1,584
+5% +$330K ﹤0.01% 2639
2018
Q4
$5.16M Buy
29,471
+391
+1% +$68.5K ﹤0.01% 2693
2018
Q3
$6.59M Buy
29,080
+2,481
+9% +$562K ﹤0.01% 2729
2018
Q2
$4.03M Buy
26,599
+27
+0.1% +$4.09K ﹤0.01% 2969
2018
Q1
$4.86M Buy
26,572
+3,143
+13% +$575K ﹤0.01% 2811
2017
Q4
$4.99M Buy
23,429
+1,235
+6% +$263K ﹤0.01% 2796
2017
Q3
$4.76M Buy
22,194
+2,572
+13% +$552K ﹤0.01% 2823
2017
Q2
$3.71M Buy
19,622
+18,989
+3,000% +$3.59M ﹤0.01% 2880
2017
Q1
$156K Sell
633
-14
-2% -$3.45K ﹤0.01% 3519
2016
Q4
$164K Hold
647
﹤0.01% 3511
2016
Q3
$132K Buy
+647
New +$132K ﹤0.01% 3429